{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:05:42Z","timestamp":1790935542383,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":723,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,1]]},"abstract":"<jats:p>Polycythaemia vera (PV) is a myeloproliferative disorder (MPD) characterized by an increased production of mature blood cells. The underlying pathogenic mechanisms behind PV are largely unknown. Thrombopoietin (TPO) is the most important cytokine for stimulation of megakaryocyte growth and formation of functional platelets. Recently, it has been shown that the receptor for TPO, c\u2010mpl, is expressed on haematopoietic stem cells, and that TPO promotes the growth of these stem cells via binding to c\u2010mpl. Quantitative or qualitative abnormalities of c\u2010mpl function could thus theoretically play a role in the pathogenesis of different MPDs. Previous studies of the integrity of the c\u2010mpl system in PV have produced conflicting results. We therefore studied c\u2010mpl protein expression using immunoblot analysis in 15 PV patients and 10 healthy controls. Seven out of 15 PV patients (47%) exhibited similar c\u2010mpl protein levels to the controls, whereas eight out of 15 patients (53%) showed either markedly reduced or absent levels of c\u2010mpl. Five of the seven c\u2010mpl\u2010positive patients had only been treated by phlebotomy, whereas six out of eight c\u2010mpl\u2010negative patients were receiving treatment with hydroxyurea, anagrelide or \u03b1\u2010interferon. Disease duration tended to be slightly longer in c\u2010mpl\u2010negative patients compared with c\u2010mpl\u2010positive patients (mean\u2003=\u200355 vs. 43 months). Tyrosine phosphorylation of JAK\u20102 in immunoprecipitates of platelets obtained after stimulation with TPO (100 and 1000\u2003ng\/ml) was normal in c\u2010mpl\u2010positive patients, whereas it could not be detected in c\u2010mpl\u2010negative patients. We therefore conclude that there exists a marked heterogeneity in c\u2010mpl protein levels and functional integrity in PV. However, it seems less likely that c\u2010mpl abnormalities <jats:italic>per se<\/jats:italic> are directly involved in the pathogenesis leading to the occurrence of PV, as c\u2010mpl levels were similar to those seen in healthy individuals in about half of the patients under study.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01794.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:20:46Z","timestamp":1047363646000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c\u2010mpl in polycythaemia vera"],"prefix":"10.1111","volume":"108","author":[{"family":"Le Blanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Samuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197610212951702"},{"key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood.V87.6.2162.bloodjournal8762162","article-title":"Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c\u2010Mpl","volume":"87","author":"Alexander W.S.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1997.tb01692.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1182\/blood.V88.7.2690.bloodjournal8872690","article-title":"Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera","volume":"88","author":"Asimakapoulos F.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200942"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/blood.V90.2.612","article-title":"Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin","volume":"90","author":"Ballmeier M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_8_2","first-page":"156","article-title":"Transcript mapping of the region of chromosome 20Q that is deleted in myeloproliferative disorders (abstract)","volume":"102","author":"Bench A.J.","year":"1998","journal-title":"British Journal of Haematology"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1998.5231"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(84)90033-5"},{"key":"e_1_2_6_11_2","first-page":"339","article-title":"Diagnosis and classification of the polycythemias","volume":"12","author":"Berlin N.I.","year":"1975","journal-title":"Seminars in Hematology"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119320"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V88.3.803.803","article-title":"Low levels of erythroid and myeloid progenitors in thrombopoietin and c\u2010mpl deficient mice","volume":"88","author":"Carver\u2010Moore K.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_14_2","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V89.7.2336","article-title":"Ultrastructure of platelet formation by human megakaryocytes cultured with the c\u2010mpl ligand","volume":"89","author":"Cramer E.M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V80.4.891.891","article-title":"Polycythemia vera II. Hypersensitivity of bone marrow erythroid, granulocyte\u2010macrophage and megakaryocyte progenitor cells to interleukin\u20103 and granulocyte\u2010macrophage colony\u2010stimulating factor","volume":"80","author":"Dai C.H.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05065.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.11.3019.3019"},{"key":"e_1_2_6_18_2","first-page":"479","article-title":"Clonality in myeloproliferative disorders (abstract)","volume":"88","author":"Gregg X.T.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.417"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05119.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(97)90021-7"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/369568a0"},{"key":"e_1_2_6_24_2","first-page":"733","article-title":"Identification of a putative molecular lesion of polycythemia vera phenotype (abstract)","volume":"86","author":"Kralovics R.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_25_2","first-page":"426","article-title":"Defective platelet aggregation in polycythemia vera is not caused by impaired calcium signalling, phospholipase D activation or decreased amounts of FAK, SYK or rhoA (abstract)","volume":"92","author":"Le Blanc K.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.00297.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1182\/blood.V82.5.1395.1395","article-title":"Oligonucleotides antisense to the proto\u2010oncogene c\u2010mpl specifically inhibits in vitro megakaryopoiesis","volume":"82","author":"Methia N.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_28_2","first-page":"488","article-title":"Impaired glycosylation of the thrombopoietin receptor in polycythemia vera platelets (abstract)","volume":"92","author":"Moliterno A.R.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802263380903"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2028.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197406132902419"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199903000-00008"},{"key":"e_1_2_6_33_2","first-page":"249","article-title":"STAT\u20105 activity is regulated normally in P. vera granulocytes (abstract)","volume":"90","author":"Rapp G.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-5710(95)00408-4"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.1.4.413k38_4_10"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90410-G"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00991.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V72.2.386.386","article-title":"A prospective long\u2010term cytogenetic study in polycythemia vera in relation to treatment and clinical course","volume":"72","author":"Swolin B.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.802720.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V82.3.877.877","article-title":"Expression of the c\u2010mpl proto\u2010oncogene in human hematological malignancies","volume":"82","author":"Vigon I.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.1.87.bloodjournal85187"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01794.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01794.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01794.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:53:51Z","timestamp":1698566031000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01794.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01794.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01794.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,1]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}